1-7 of 7
Daniel Addison
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cardiovascular Toxicities Associated with Bispecific T-Cell Engagers

Ahmed Sayed, Malak Munir, Sanam Ghazi, Mussammat Ferdousi, Satyam Krishan, Adnan Shaaban, Alma Habib, Onaopepo Kola-Kehinde, Patrick Ruz, Sarah Khan, Sneha Sharma, Alexa Mera, Narendranath Epperla, Daniel Addison
Journal: Blood
Blood (2023) 142 (Supplement 1): 2882.
https://doi.org/10.1182/blood-2023-189603
Published: 2023
Journal Articles

Gemcitabine and Liposomal Doxorubicin (GemDox) for the Treatment of Relapsed and Refractory T-Cell Lymphomas

Zachary Braunstein, Allyson Waller, Emily Dotson, Eric McLaughlin, Walter Hanel, John C Reneau, Daniel Addison, Pierluigi Porcu, Jonathan E. Brammer
Journal: Blood
Blood (2023) 142 (Supplement 1): 4453.
https://doi.org/10.1182/blood-2023-184583
Published: 2023
Journal Articles

Ventricular arrhythmias and sudden death events following acalabrutinib initiation

Clinical Trials & Observations Brief Report
Seema A. Bhat, John Gambril, Leylah Azali, Sunnia T. Chen, Lindsay Rosen, Marilly Palettas, Tracy E. Wiczer, Sujay Kalathoor, Qiuhong Zhao, Kerry A. Rogers, Adam Kittai, Michael Grever, Farrukh Awan, Patrick Ruz, John C. Byrd, Jennifer Woyach, Daniel Addison
Journal: Blood
Blood (2022) 140 (20): 2142–2145.
https://doi.org/10.1182/blood.2022016953
Published: 2022
Includes: Supplemental data
Journal Articles

Cardiac Arrhythmias and Mortality after Hematopoietic Stem Cell Transplant (HSCT): A Systematic Review and Meta-Analysis

Saad Ullah Malik, Zachary Braunstein, Sumithira Vasu, Sam Penza, Ayman Saad, Nathan Denlinger, Marcos J.G. de Lima, Ajay Vallakati, Ragavendra Baliga, Samantha Jaglowski, Jonathan E. Brammer, Daniel Addison
Journal: Blood
Blood (2021) 138 (Supplement 1): 2918.
https://doi.org/10.1182/blood-2021-152223
Published: 2021
Journal Articles

Evaluation of the Incidence and Risk Factors Associated with Major Cardiovascular Events in Patients Receiving Acalabrutinib Therapy

Leylah Azali, PharmD, Lindsay Hazelden, PharmD, Tracy Wiczer, PharmD, Marilly Palettas, Rebekah Thomas, Connor Aossey, James S. Blachly, MD, Michael R. Grever, MD, Adam S. Kittai, MD, Kerry A. Rogers, MD, John C. Byrd, MD, Jennifer A. Woyach, MD, Daniel Addison, MD, Seema A Bhat, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-137800
Published: 2020
Journal Articles

Hypertension and incident cardiovascular events following ibrutinib initiation

Clinical Trials & Observations
Tyler Dickerson, Tracy Wiczer, Allyson Waller, Jennifer Philippon, Kyle Porter, Devin Haddad, Avirup Guha, Kerry A. Rogers, Seema Bhat, John C. Byrd, Jennifer A. Woyach, Farrukh Awan, Daniel Addison
Journal: Blood
Blood (2019) 134 (22): 1919–1928.
https://doi.org/10.1182/blood.2019000840
Published: 2019
Includes: Supplemental data
Journal Articles

Hypertension Development, Management, and Cardiovascular Events Following Ibrutinib Initiation for Hematologic Malignancies

Tyler Dickerson, PharmD, Tracy Wiczer, Allyson Waller, Jennifer Philippon, Devin Haddad, Avirup Guha, Kyle Porter, Kerry A. Rogers, MD, Jennifer A. Woyach, MD, John C. Byrd, MD, Daniel Addison, Farrukh T. Awan, MD MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4423.
https://doi.org/10.1182/blood-2018-99-110345
Published: 2018